You have access
First-line Gemcitabine Versus Treatment of Physician’s Choice for Metastatic Breast Cancer: A Prospective Cohort Study
SHINYA YAMAMOTO, KAZUTAKA NARUI, TAKASHI ISHIKAWA, SHOKO ADACHI, KAZUHIRO SHIMADA, DAISUKE SHIMIZU, AKIMITSU YAMADA, SADATOSHI SUGAE, MIKIKO TANABE, MARI OBA, SATOSHI MORITA, TAKAKO DOI, SATOSHI HASEGAWA, TOMOYUKI MORITA, AYAKO KITO, TAKASHI CHISHIMA, YASUSHI ICHIKAWA and ITARU ENDO
Anticancer Research March 2021, 41 (3) 1671-1676; DOI: https://doi.org/10.21873/anticanres.14930